Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-03-21

Clinical Trial Update: Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia

View source ↗

Summary

A retrospective analysis assessing the safety and efficacy of hydroxychloroquine in immune thrombocytopenia, including cases with systemic lupus erythematosus, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Henri Mondor University Hospital | Conditions: Immune Thrombocytopenia, Systemic Lupus Erythematosus | Status: COMPLETED